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ABSTRACT  
PURPOSE: Studies attributing gains in strength and lean body mass (LBM) to creatine 
monohydrate (CrM) during resistance exercise (RE) training have not assessed these changes 
alongside cellular and sub-cellular adaptations. Additionally, CrM-treated groups have seldom 
been compared with a group receiving a placebo similar in nitrogen and energy. The purpose of 
this study was to examine the effects of a CrM-containing protein-carbohydrate (PRO-CHO) 
supplement in comparison to a supplement containing a similar amount of nitrogen and energy on 
body composition, muscle strength, fiber-specific hypertrophy and contractile protein accrual 
during RE training. METHODS: In a double-blind, randomized protocol, resistance-trained 
males were matched for strength and placed into one of three groups: protein (PRO), protein-
carbohydrate (PRO-CHO) or the same PRO-CHO supplement (1.5g/kg body wt/day) containing 
CrM (Cr-PRO-CHO) (0.1g/kg body wt/day). Assessments were completed the week before and 
after a 10 week structured, supervised RE program; strength (1RM, three exercises), body 
composition (DEXA) and vastus lateralis muscle biopsies for determination of muscle fiber type 
(I, IIa, IIx), cross-sectional area (CSA), contractile protein and creatine content. RESULTS: Cr-
PRO-CHO provided greater improvements in 1RM strength. At least 40% of the strength 
improvements could be attributed to hypertrophy of muscle involved in this exercise. Cr-PRO-
CHO also resulted in greater increases in LBM, fiber CSA and contractile protein compared to 
PRO and PRO-CHO. CONCLUSIONS: In RE-trained participants, supplementation with Cr-
PRO-CHO provided greater muscle hypertrophy than an equivalent dose of PRO-CHO and this 
response was apparent at three levels of physiology (LBM, fiber CSA and contractile protein 
content). 
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INTRODUCTION 
Paragraph 1. Supplementation with creatine monohydrate (CrM) has been consistently shown to 
promote greater gains in lean body mass (LBM) and strength compared to placebo treated groups 
(20). However, in most cases, the CrM-treated group was often not compared with a group that 
received a placebo containing protein and an equivalent amount of energy (9; 13; 25; 27).   Only 
one resistance exercise (RE) training study has compared the effects of a CrM-containing 
supplement (10g CrM, 75g CHO) with a supplement containing a similar amount of nitrogen 
(protein) and energy (10g milk protein, 75g CHO) (24). This study reported that CrM treatment 
provided no greater gain in strength, LBM or muscle fiber hypertrophy (24). However, this study 
utilized a group of inactive males (exercised less than twice a week prior to the study). While the 
influence of training status on the effects of supplementation is unknown, previous work 
involving CrM supplementation and RE-trained individuals has shown that treatment enabled the 
participants to progress at a more rapid rate, which was reflected by the larger strength gains and 
greater volume of work completed during the workouts (27). Therefore, unlike inexperienced 
participants, it may be possible that RE-trained individuals experience strength and LBM gains 
that are of greater magnitude during training.  
Paragraph 2. Longitudinal studies that have attributed changes in LBM to supplementation 
during RE training seldom report these changes alongside adaptations at the cellular level (i.e., 
fiber-specific, type-I, IIa, IIx hypertrophy) (5; 6; 8; 13; 25). Those that have assessed fiber-
specific hypertrophy in response to supplementation (24; 27) have not confirmed this response 
with changes at the sub-cellular level (i.e., contractile protein content). Therefore, the aim of this 
study was to use a group of RE-trained participants to examine the effects of a CrM-containing 
 
 4
protein-carbohydrate (PRO-CHO) supplement in comparison to a supplement containing a 
similar amount of nitrogen and energy on strength, body composition and fiber-specific (i.e., 
type-I, IIa, IIx) hypertrophy as well as muscle Cr and contractile protein content.  The hypothesis 
was that in RE-trained individuals, a CrM-containing PRO-CHO supplement would provide 
greater benefits (i.e. muscle strength and hypertrophy) compared to a PRO-CHO supplement 
containing a similar amount of nitrogen and energy.  
 
METHODS 
Participants 
Paragraph 3: Thirty-one recreational male bodybuilders met the requirements to commence this 
study that involved pre-post assessments and supplementation during 10 weeks of RE training 
(baseline characteristics are presented in table 1). To qualify as participants the men (a) had no 
current or past history of anabolic steroid use, (b) had been training consistently (i.e., 3-5 days 
per week) for the previous six months, (c) submitted a detailed description of their current 
training program, (d) had not ingested any ergogenic supplement for 12-weeks prior to the start 
of this investigation, and (e) agreed not to ingest any other nutritional supplements, or non-
prescription drugs that may affect muscle growth or the ability to train intensely during the study. 
All participants were informed of the potential risks of the investigation before signing an 
informed consent document approved by the Human Research Ethics Committee of Victoria 
University and the Department of Human Services, Victoria, Australia. All procedures 
conformed to National Health and Medical Research Council guidelines for the involvement of 
human subjects for research and conformed to the policy statement regarding the use of human 
subjects and written informed consent published by Medicine & Science in Sports & Exercise®. 
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Paragraph 4: After baseline assessments, the men were matched for maximal strength (1RM) in 
three weight lifting exercises (see strength assessments) and then randomly assigned to one of 
three supplement groups in a double-blind fashion; protein-only (n=10) (PRO), protein-
carbohydrate (n=11)  (PRO-CHO), or the same protein-carbohydrate supplement that contained 
CrM (n=10) (Cr-PRO-CHO). 
Supplementation  
Paragraph 5. The Cr-PRO-CHO group consumed the exact same supplement as the PRO-CHO 
group (50% whey isolate; 50% glucose). The only difference was the Cr-PRO-CHO supplement 
contained a dose of CrM (0.1 g kg -1day -1). Participants were instructed to consume 1.5 grams of 
the supplement per kilogram of body weight per day (1.5 g kg -1day -1) for the 10 week program 
while maintaining their habitual daily diet.  The chosen supplement dose was based on previously 
reported intakes of this population (14). For example, an 80kg participant in the PRO-CHO group 
consumed 120 g day -1 of a supplement that contained  52g protein, 59g carbohydrate, <0.6g fat 
and 1877kJ (449 kcal). An 80kg participant in the Cr-PRO-CHO group consumed 120g-1day of a 
supplement that supplied 48g protein, 53g carbohydrate, <0.6 fat, 8.4g CrM and 1710kJ (409 
kcal). Another matched group (PRO) were provided a protein only supplement (whey isolate) 
(1.5 g kg -1day -1) that provided an 80kg participant (120g dose) with 103g protein, <6g 
carbohydrate, <1.2g fat and 1864 kJ (447 kcal). All supplements were supplied by AST Sport 
Science, Golden, CO. USA, and were tested to comply with label claims before leaving the place 
of manufacture. The protein was also independently assessed by Naturalac Nutrition LTD (Level 
2/18 Normanby Rd Mt Eden, New Zealand) on two separate occasions, and matched labeled 
ingredients on both occasions.  
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Paragraph 6. The participants were asked to consume their supplement dose in three equal 
servings throughout the day (described with measuring scoops provided). For example, one 
serving was consumed mid-morning, another soon after the workout in the afternoon (or similar 
time on non-training days), and a final serving was taken in the evening before sleep. The 
participants were weighed on a Seca 703 stainless steel digital medical scale (Seca, Perth, WA) 
every week to track body mass and shown how to adjust the supplement dose as required. The 
supplements were provided in identical containers with sealed, tamper-proof lids. Participants 
were given approximately a one-week supply of the supplement at the start of each week and 
asked to return the container before they received the next weeks supply as an act of compliance 
to the dosing procedure. In addition to having to return the container, the participants were asked 
to document the time of day they took the supplement in nutrition diaries that were provided. The 
participants’ diets were monitored and assessed as previously described (7). In brief, each 
participant was asked to submit three written dietary recordings; one before and two during the 
study (each recording consisted of 3-days) for the calculation of macronutrient and energy intake. 
Energy intake is expressed in kcal-1kg of body weight per day; macronutrients are expressed in g 
kg -1 of body weight per day. The participants were asked to report any adverse events from the 
supplements in the nutrition diaries provided. No adverse events were reported by the 
participants.    
Resistance training protocol 
Paragraph 7. Questionnaires demonstrated that the participants had been training consistently 
(i.e., 3-5 days per week) for at least six months before expressing interest in this investigation. 
However, to ensure the participants were trained and to minimize the impact of a new program on 
strength and hypertrophy adaptations, all participants underwent a structured RE program for ~12 
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weeks that was very similar to the one used in the study (Max-OT™, AST Sport Science, Golden, 
CO, USA) (8). No supplementation was permitted during this pre-trial phase. Once the pre-trial 
training phase was completed, participants underwent baseline assessments. The 10 week 
training/supplementation program began the week immediately after baseline assessments.  In 
brief, the program was designed specifically to increase strength and muscle size. It consisted of 
high-intensity (overload) workouts using mostly compound exercises with free weights. Training 
intensity for the program was determined initially using repetition maximums (RM) from 
strength tests. However, once a designated RM was achieved in each phase, the participants were 
encouraged by the trainer to increase the weight used. This progressive overload program was 
divided into 3 phases, Preparatory (weeks 1-2) (10 RM), Overload Phase-1 (weeks 3-6) (8-6 
RM), and Overload Phase-2 (weeks 7-10) (6-4 RM). Qualified personnel supervised each 
participant on a one-to-one basis, every workout. Aside from the personal training each 
participant received during the 10 week program, they also kept training diaries to record 
exercises, sets, repetitions performed and the weight utilized throughout the program and these 
were viewed by the trainer on a weekly basis. The following assessments occurred in the week 
before and after the 10-week RE program.   
Assessments 
Paragraph 8. Strength assessments consisted of the maximal weight that could be lifted once 
(1RM) in three weight training exercises: barbell bench press, squat and cable pulldown. 
Recognized 1RM testing protocol and exercise execution guidelines were followed as previously 
documented (1). Briefly, the participant’s maximal lift was determined within no more than five 
single repetition attempts following three progressively heavier warm up sets. Participants were 
required to successfully lift each weight before attempting a heavier weight. Each exercise was 
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completed before the next attempt and in the same order. Reproducibility for these tests was 
determined on 2 separate occasions; intra class correlations (ICC) and standard error of 
measurement (SEM) for 1RM tests were bench press r = 0.98, SEM 1.0kg; squat r =  0.99, SEM 
2.5kg;  pulldown r = 0.98, SEM 2.5kg.     
Paragraph 9. Lean body mass (total fat free mass), fat mass and body fat percentage were 
determined using a Hologic QDR-4500 dual energy x-ray absorptiometry (DEXA) with the 
Hologic version V 7, REV F software (Waltham, MA). Whole body scans were performed on the 
same apparatus, by the same licensed operator. Quality control calibrations were performed as 
previously described (8). Participants were scanned at the same time of the day, that is, in the 
morning in a fasted state. For longitudinal studies in which relatively small changes in body 
composition are to be detected, whole body scanning with this instrument has been shown to be 
accurate and reliable (CV 0.8-2.8%) (19) 
Paragraph 10. Muscle biopsies for determination of muscle fiber type, cross-sectional area 
(CSA), contractile protein content and Cr concentrations were taken in the week before and after 
the RE program. Biopsies (100-450mg) were taken using the percutaneous needle technique with 
suction to ensure adequate sample size (10) at a similar depth in the vastus lateralis muscle by the 
same medical practitioner. A small part of the sample was immediately frozen for assessment of 
contractile protein content and Cr. The remaining tissue was mounted using OCT medium and 
snap frozen in isopentane pre-cooled in liquid nitrogen and stored at -80o C for histochemical 
analysis to classify muscle fiber types-I, IIa and IIx based on the stability of their ATPase 
activity, as previously described (7).  Fiber type percentages and CSA were determined from 
sections containing a mean of 210 (range 130-400) fibers. Samples were measured on two 
separate occasions for day to day reproducibility ICC and SEM for fiber type distribution were 
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type I r = 0.82, SEM 1.8%;  type IIa r = 0.94, SEM 1.3%;  type IIx r = 0.94, SEM 1.2%. For 
mean area of fiber type I r = 0.97, SEM 87µm2; type IIa r = 0.98, SEM 100µm2; type IIx r = 0.97, 
SEM 141µm2. Approximately 5 mg of muscle was used to determine contractile protein content 
as detailed by Beitzel et al. (3) and reported previously (7). Samples were run twice on two 
separate occasions (ICC r = 0.98, SEM 2.1 mg g-1). Two mg of muscle was used to analyze Cr 
concentrations using fluorimetric techniques as in Harris et al. (11), with data expressed as mmol 
kg-1 dry weight (ICC  r = 0.88, SEM 22).  
Statistics 
Paragraph 11: Statistical evaluation of the data was accomplished by two-way repeated 
measures analysis of variance (ANOVA) with group (supplement) and time (training) as the 
factors using SPSS statistical analysis software (SPSS v 11.0; Chicago, Illinois). Where 
significant main effects were identified by ANOVA, tukeys post hoc analysis was performed to 
locate differences. Deltas for each variable were analyzed with a one-way ANOVA. Preliminary 
power testing of expected changes in strength and body composition were based on previous data 
obtained by our laboratory (7; 8) and others (24; 27; 29). This testing revealed that 8 participants 
were required per group to obtain significance at an alpha level of 0.05 and a power of 0.8. Test-
retest reliability was quantified using the intraclass correlation coefficient (ICC) two-way 
ANOVA (mixed effects model) and the SEM (28). Simple regression was used to determine 
significant relationships among the deltas for selected variables. A p value of less than 0.05 was 
designated to indicate statistical significance. 
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RESULTS 
Starting characteristics 
Paragraph 12. Baseline characteristics are presented in table 1. There were no differences 
between the groups in any variables at the start of the study (P > 0.05).  
Dietary Analyses 
Paragraph 13. Table 2 shows the average of three day written dietary recalls for energy (Kcal kg 
-1 d -1) carbohydrate and protein (g kg -1 d -1) of the groups before, and in the first and last week of 
the training program. Data does not include supplementation. No differences were identified 
between the groups or across time with regard to energy or macronutrient intake (P > 0.05).  
Body Composition 
Paragraph 14. Body mass and DEXA determined body composition are presented in table 3, 
with changes from baseline presented in figure 1. While all groups demonstrated an increase (P < 
0.05) in body mass after the training program, a group x time interaction (P < 0.05) was detected; 
the PRO-CHO and Cr-PRO-CHO groups demonstrated a greater gain in body mass (post hoc P < 
0.05) compared to the PRO group. All groups demonstrated an increase (P < 0.05) in lean mass 
(LBM) after the training program. However, a group x time interaction (P < 0.01) for LBM was 
detected; the Cr-PRO-CHO group showed a greater gain in LBM compared to the PRO and 
PRO-CHO groups (post hoc P < 0.05). A group x time interaction (P < 0.05) for fat mass and 
body fat percent was also observed. When compared to the PRO-CHO group, the PRO and Cr-
PRO-CHO groups demonstrated a significant decrease in fat mass and body fat percent (post hoc 
P < 0.05). 
Strength 
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Paragraph 15. Table 3 also presents the results of 1RM strength assessments and changes from 
baseline are presented in figure 2.  All groups demonstrated an improvement (P < 0.05) in 
strength in each exercise after the training program. However, a group x time interaction (P < 
0.05) was detected for the barbell squat, bench press and pulldown. The Cr-PRO-CHO group 
demonstrated a greater gain in strength in each of these exercises compared to the PRO and PRO-
CHO groups (post hoc P < 0.05). No other differences between the groups were detected. 
Muscle characteristics   
Paragraph 16. There were no changes between the groups or across time with regard to fiber 
type proportions (table 4). All groups demonstrated an increase in CSA across all muscle fiber 
types (P < 0.05) after the training program, however a group x time interaction (P < 0.05) in CSA 
of both type-II fiber subgroups was detected (table 4). The Cr-PRO-CHO group demonstrated a 
greater increase in CSA in the type-IIa and IIx fibers compared to the PRO and PRO-CHO 
groups (post hoc P < 0.05) (figure 3). A group x time interaction (P < 0.05) was also observed for 
contractile protein content. The Cr-PRO-CHO group showed a greater increase in contractile 
protein content compared to the PRO and PRO-CHO groups (post hoc P < 0.05) (figure 4). Table 
4 also presents muscle Cr data from samples taken before and after the training program. No 
differences between the groups or across time were detected.   
Correlations 
Paragraph 17. For all participants combined, positive correlations (P < 0.05) were detected 
between changes in CSA in the type-II fibers and strength gained in the 1RM squat exercise (r = 
0.677) (figure 5). A correlation was also detected between the changes in contractile content 
(mg/g) and strength gained in squat exercise (1RM) (r = 0.643; P < 0.01) (figure 6).  For all 
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participants combined, a positive correlation was also detected between the changes in LBM and 
strength (1RM) in the squat (r = 0.661; P < 0.01) (figure 7).   
 
DISCUSSION 
Paragraph 18. The most important finding of this investigation was that in RE-trained 
individuals, a CrM-containing PRO-CHO supplement provided significantly greater gains in 1RM 
strength and muscle hypertrophy compared to supplementation with an equivalent dose of PRO-
CHO or PRO during 10 weeks of training. A significantly greater muscle hypertrophy response 
from the addition of CrM was evident at three different levels of physiology. That is, the CrM-
treated group demonstrated a greater gain in LBM, hypertrophy of the type-IIa and IIx fibers, and 
increase in contractile protein. This is important, as we aware of no other research that has 
confirmed improvements in body composition via RE training and CrM supplementation with 
hypertrophy responses at the cellular (i.e., fiber-specific hypertrophy) and sub-cellular level (i.e., 
contractile protein content). Therefore, these results support the hypothesis that, in RE-trained 
individuals, a CrM-containing PRO-CHO supplement provides greater adaptations than a PRO-
CHO supplement containing a similar amount of nitrogen and energy.  
Paragraph 19. Several RE training studies have reported greater increases in strength and LBM 
in participants who consumed CrM as compared with a placebo (5; 6; 9; 13; 25). However, only 
one has compared the effects of a CrM-containing supplement with a supplement containing a 
similar amount of protein and energy (24). Tarnopolsky et al. (24) utilized previously inactive 
participants and daily supplementation with either 10g CrM + 75g CHO 1252kJ (300kcal) or 10g 
protein + 75g CHO 1420kJ (340kcal). When compared in this manner, Tarnopolsky et al. (24) 
concluded that CrM supplementation provided no greater gains in strength, LBM or muscle fiber 
 
 13
hypertrophy. However, whereas Tarnopolsky et al. (24) utilized previously inactive participants, 
the present study utilized RE-trained participants, and demonstrated significantly greater 
improvements in strength (three of three assessments) and muscle hypertrophy (three of three 
assessments) from treatment with CrM. Generally, untrained participants experience strength and 
lean mass changes that are of greater magnitude compared to RE-trained athletes (9). However, 
the influence of training status on the effects of supplements such as CrM is unknown. Previous 
work involving CrM supplementation and RE-trained individuals has shown that treatment 
enabled the participants to progress at a more rapid rate (27). This was reflected by the larger 
1RM strength gains and greater volume of work completed during the workouts.  I.e., more 
repetitions completed with heavier weight (27). Therefore, unlike inexperienced participants, it 
may be possible that RE-trained individuals experience strength and LBM gains that are of greater 
magnitude during training. Addionally, muscle Cr uptake is shown to be enhanced by 
macronutrient consumption (23) and post-exercise supplementation (21). In the present study, the 
CrM-treated participants consumed CrM with protein and carbohydrate and one of these servings 
were taken immediately after each workout. The results of this trial would appear to support the 
suggestion that CrM supplementation provides greater benefits in RE-trained individuals. 
However, a clear mechanism underlying these benefits remains some what elusive.  
Paragraph 20. Improvements in muscular performance during high intensity contractions are 
associated with ATP resynthesis as a consequence of increased PCr availability in muscle via 
CrM supplementation (9; 11). Increasing the availability of PCr via supplementation is not only 
thought to enhance cellular bioenergetics of the phosphagen system but also the shuttling of high-
energy phosphates between the mitochondria and cytosol to increase the availability of energy for 
contractile protein synthesis (2). Creatine is taken up by muscle where it appears to stimulate 
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transcription factors that regulate the synthesis of contractile proteins (29).  Willoughby & 
Rosene (29) have reported an enhanced hypertrophy response from RE and supplementation (i.e., 
increase in strength, LBM and thigh volume) as well as alterations at the molecular level that may 
explain these benefits. Supplementation with CrM (6 g day -1 for 12 weeks) resulted in a greater 
increase in LBM (assessed by skin fold caliper), thigh volume, (relative) muscle strength, and 
contractile protein content as well as up regulation of the genes and myogenic regulatory factors 
associated with (myosin heavy chain) contractile protein synthesis (29). An analytical review of 
22 studies involving supplementation during RE training demonstrated that CrM clearly enhances 
maximum strength and weightlifting performance (maximal repetitions at a given percent of maximal 
strength) and this benefit was attributed to increased Cr availability during intense muscle 
contraction (20). More recently, Olsen et al. (16) reported that CrM supplementation during 16 
weeks of RE amplified the training-induced increase in satellite cell number and myonuclei 
concentration in human skeletal muscle fibers, thereby allowing an enhanced muscle fiber growth 
in response to strength training. Therefore, supplementation with CrM may result in superior 
strength and hypertrophy responses (20) by inducing greater satellite cell number and myonuclei 
concentration (16) alongside transcriptional changes in muscle gene expression (29) which may 
contribute to, or be a product of, CrM’s ability to enhance the bioenergetics of the phosphagen 
system (2; 11).  Despite the clear beneficial effect of CrM that was observed in this study, 
metabolite assessments revealed no significant change in muscle Cr content at the end of the 
program. The CrM dose used in this study was based on others that have reported improvements 
in muscle hypertrophy and strength performance with small daily doses (6 g day -1) (with no 
loading phase) similar to the dose utilized (0.1 g kg -1day -1) in this study.  However, it may be 
that small daily doses of CrM for a prolonged duration (10 weeks) may not promote elevated 
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muscle Cr concentrations during intense RE training. For instance, despite a loading phase (20 g 
day -1, 5 days) that provided a 25% increase in resting muscle Cr concentrations in the first week, 
Volek et al., (27) reported that supplementation (5 g day-1) for a further 11 weeks resulted in only 
a ~10% increase by the end of a 12 week training/supplementation program. Van Loon et al. (26) 
demonstrated that a small maintenance dose (2-3 day g-1 for 6 weeks) in sedentary individuals 
failed to maintain high Cr muscle concentrations that were achieved by a CrM loading phase (20 
day g-1, 5days). In fact, after the 6 week maintenance phase, muscle Cr levels had returned to pre 
supplementation values (26). Although the results of the current investigation show clearly that 
CrM provided significantly greater muscle hypertrophy and strength, metabolite assessments 
revealed no significant change in muscle Cr content at the end of the program. The benefits of 
CrM are thought to be dependant on its accumulation within the cell (5; 9; 11; 20). As the 
advantages of supplementation may be applicable to a wide sector of the population, further 
studies should investigate strategies that create and maintain high muscle Cr concentrations 
during exercise training.  
Paragraph 21. The CrM-treated group demonstrated a significantly greater increase in 
contractile protein content (mg g -1 of muscle) compared to the other groups after the training 
program (figure 4). This result reflects the changes in CSA and LBM that were also detected. An 
increase in contractile protein is thought to be an important stimulus that results in an increase in 
muscle fiber CSA (17). RE-induced muscle fiber hypertrophy is thought to be primarily 
responsible for improvements in force production and strength that are observed in RE-trained 
participants (22). When all participants were combined, a strong relationship between changes in 
muscle fiber CSA of the type II fibers (IIa and IIx grouped) and strength improvements in the 
squat exercise were evident (figure 5). A similar relationship between changes in contractile 
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protein content or LBM and strength improvements in the squat was also detected (figures 6 and 
7).  The r values obtained suggest that a substantial portion (at least 40%) of the strength 
improvements observed across all groups could be attributed to the changes in skeletal muscle 
morphology. These correlations reflect a direct relationship between muscle adaptation 
(hypertrophy) and an improvement in functional strength. Obviously, the barbell squat exercise 
was the focus of these correlation assessments, simply because, unlike the bench press and 
pulldown exercise, the vastus lateralis is recruited heavily during this exercise and was the 
muscle from which the biopsy samples were obtained. 
Paragraph 22. Aside from skeletal muscle morphology, the improvements in 1RM strength 
observed in this trial must also be attributed to the benefits of personalized coaching/supervision. 
Although the participants in our study were experienced, none had ever received personal training 
by a qualified instructor (the personal training only occurred during the 10 week trial, not the 
training program prior to the study). Personalized instruction of the participants was a major 
strength of this study as this level of supervision is shown to provide better control of workout 
intensity and greater strength improvements during training (15). This level of supervision was 
important to our hypothesis as it would ensure the best chance of enhanced physiological 
adaptations from an interaction between training and CrM supplementation. This is based on the 
premise that those taking the CrM would obtain a greater anabolic response from each workout 
and progress at a faster rate. It is important to remember that the instructor was blinded to the 
supplement groups, yet the CrM-treated group demonstrated significantly greater gains in 1RM 
strength (in three of three assessments) and greater muscle hypertrophy responses (in three of 
three assessments), thus supporting the hypothesis presented.  
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Paragraph 23. Another interesting finding from this study was the influence of the different 
supplements on body composition. While all groups demonstrated a gain in body mass after the 
training program, the Cr-treated group demonstrated a significantly greater gain in body mass 
compared to the PRO group but not the PRO-CHO group. However, there were differences in the 
composition of these changes in mass. Compared to the PRO-CHO group, the Cr-PRO-CHO 
group and the PRO groups demonstrated a decrease in fat mass and body fat percent (table 3; 
figure 1). The exact reasons for these different responses to the various supplements are not clear. 
A decrease in body fat and/or body fat percent in response to whey protein supplementation (6-10 
weeks) is a phenomenon that has been reported previously in rodents (4) and humans undertaking 
RE training (7). Whey protein supplementation has been shown to induce greater lipid oxidation 
during and after exercise compared to casein and CHO; a response that resulted in a greater 
utilization of body fat for fuel and a reduction in body fat (4). However, this does not explain the 
contrasting body composition changes observed in the Cr-PRO-CHO and PRO-CHO groups. 
Both of these groups consumed the same supplement; the only difference being the relatively 
small amount of CrM present in the Cr-PRO-CHO supplement (approximately 7%).  Despite this, 
the Cr-treated group demonstrated a reduction in fat mass (and body fat percentage) when 
compared to the PRO-CHO group. CrM does not appear to provide any benefit with regard to fat 
metabolism (12). Therefore, the improvement in body composition observed from CrM-
supplementation is most like due to the large accretion of LBM that was observed in this group, 
which was on average, 6kgs. This extra muscle mass would almost certainly have had a positive 
influence on resting metabolic rate and therefore, fat metabolism, particularly in active individuals 
that consume the same relative energy intake (per kg of body mass) for a prolonged period of time 
(18), as was the case in this study. If the addition of CrM to a PRO-CHO supplement does 
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enhance LBM gains and improve body composition during training as observed in this study, this 
may have specific implications for some populations. For example, those that desire maximum 
gains in LBM, strength and muscle hypertrophy without an increase in fat mass will benefit from 
a CrM-containing PRO-CHO supplement. However, for others that desire a gain in body mass in 
general, CrM may not be required. Alternatively, athletes that desire strength and muscle 
hypertrophy with only a relatively modest increase in body mass may opt for supplementation 
with whey protein alone.  
Paragraph 24. In conclusion, this study used a group of RE-trained participants to examine the 
effects of a CrM-containing (0.1 g kg -1day -1) PRO-CHO supplement in comparison to the same 
PRO-CHO supplement (without CrM) during 10 weeks of RE training. Although both 
supplements were similar in energy and nitrogen content, the group who received CrM 
demonstrated greater gains in 1RM strength in three exercises and these improvements were 
supported by a greater hypertrophy response that was apparent at three different levels; LBM, 
muscle fiber CSA and contractile protein content. Therefore, in RE-trained individuals, the 
presence of CrM in a PRO-CHO supplement results in significantly greater adaptations during RE 
training than supplementation without CrM. 
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FIGURE CAPTIONS 
 
 
Figure 1. Body mass and composition changes *Significantly different than PRO-CHO; 
†Significantly different than PRO (P < 0.05). 
  
Figure 2. 1RM Strength Changes  *Significantly different than PRO-CHO; † Significantly 
different than PRO (P < 0.05) 
  
Figure 3. Changes in muscle fiber CSA (types-I, IIa and IIx) *Significantly different than PRO-
CHO; †Significantly different than PRO (P < 0.05). 
 
Figure 4. Changes in contractile protein content (mg/g of muscle) *Significantly different than 
PRO-CHO; †Significantly different than PRO (P < 0.05). 
 
Figure 5 Relationship between type-II muscle fiber hypertrophy and 1RM strength improvements 
in the squat.  
 
Figure 6.  Relationship between change in contractile protein content and 1RM strength gains in 
the squat.  
 
Figure 7. Relationship between change LBM and 1RM strength improvements in the squat 
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r  = 0.643; P = 0.001
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Figure 7. 
r = 0.661; P  = 0.001
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TABLES 
 
 
Table 1. Baseline Characteristics 
 PRO      PRO-CHO Cr-PRO-CHO P 
Age (yrs) 25 ± 4 26 ± 3 26 ± 5  0.799 
Training age (yrs) 4 ± 2  4 ± 1 4 ± 5  0.871 
Height (cm) 177 ± 4 177 ± 4 179 ± 5 0.509 
Lean mass (kg) 69 ± 8 67 ± 9 70 ± 12  0.729 
Fat mass (kg) 16 ± 5 13 ± 5 16 ± 9 0.391 
CSA type-I (µm2) 2895 ± 511 3079 ± 1365 3129 ± 718 0.887 
CSA type-IIa (µm2) 4519 ± 639 4662 ± 1326 4528 ± 1014 0.959 
CSA type-IIx (µm2) 3798 ± 734 4370 ± 1405 3905 ± 901 0.586 
1RM Bench (kg) 110 ± 13 112 ± 20 108 ± 13 0.866 
1RM Squat (kg) 120 ± 15 127 ± 29 122 ± 24 0.789 
1RM Pulldown (kg) 105 ± 9 108 ± 13 108 ± 15 0.834 
Data presented as mean ± SD 
 
 
  
Table 2.  Dietary Analyses (means ± SD) 
 
 PRO PRO-CHO Cr-PRO-CHO P  Group x Time  
Energy intake (kJ/kg/day) 
before 
week 1 
week 10 
 
135.7 ± 15.1 
126.0 ± 14.2 
126.0 ±  8.0 
 
137.3 ± 15.5 
137.3 ± 13.0 
131.5 ± 14.7 
 
138.2 ± 17.6 
126.0 ± 15.5 
123.1 ± 10.5 
 
 
0.264 
Carbohydrate (g/kg/day) 
before 
week 1 
week 10 
 
3.0 ± 0.8 
3.0 ± 0.5 
2.8 ± 0.5 
 
3.3 ± 0.6 
3.3 ± 0.7 
3.2 ± 0.5 
 
3.1 ± 0.7 
2.8 ± 0.6 
3.0 ± 0.4 
 
 
0.653 
Protein  (g/kg/day) 
before 
week 1 
week 10 
 
2.3 ± 0.5 
1.7 ± 0.2 
1.7 ± 0.2 
 
2.0 ± 0.8 
1.7 ± 0.2 
1.8 ± 0.6 
 
1.8 ± 0.3 
1.6 ± 0.3 
1.6 ± 0.2 
 
0.385 
 
 
 
 
 
Table 3. Body mass, composition and 1RM strength (mean ± SE)  
 
 PRO PRO-CHO Cr-PRO-CHO P  Group x Time 
Body mass (kg)  
PRE 
POST #
 
 88.0 ± 3.6 
 92.2 ± 3.5 
 
   82.0 ± 4.0 
    88.8 ± 3.9†
 
 89.6 ± 6.5 
  96.7 ± 2.7†
0.001 
Lean mass (kg)  
PRE 
POST #
 
69.1 ± 2.5 
74.0 ± 2.5 
 
66.5 ± 2.8 
70.6 ± 2.9 
 
   69.6 ± 3.8 
      76.5 ± 4.2*†
0.001 
Fat mass (kg)  
PRE 
POST 
 
 16.2 ± 1.7 
  14.6 ± 1.5* 
 
12.7 ± 1.4 
14.0 ± 1.2 
 
   15.9 ± 2.8 
    15.4 ± 2.5* 
0.01 
Fat % 
PRE 
POST 
 
17.2 ± 1.5 
 13.6 ± 1.2* 
 
15.1 ± 1.1 
15.9 ± 0.8 
 
    16.3 ± 0.9 
     14.1 ± 1.4* 
0.01 
Squat (kg) 
PRE 
POST #
 
119.6 ± 4.9 
144.8 ± 4.7 
 
126.7 ± 8.7 
149.8 ± 9.8 
 
 122.2 ± 7.6 
   156.9 ± 9.6*†
0.03 
        Bench press (kg) 
PRE 
POST#
 
110.3 ± 4.0 
121.6 ± 4.1 
 
112.0 ± 6.0 
121.0 ± 6.0 
 
108.3 ± 4.0 
    130.7 ± 5.3*†
0.001 
Pulldown (kg) 
PRE 
POST #
 
105.2 ± 2.9 
117.3 ± 3.0 
 
107.8 ± 3.8 
119.9 ± 4.8 
 
108.4 ± 4.8 
   127.1 ± 4.9*†
0.005 
*Greater change than PRO-CHO; †Greater change than PRO; # training effect all groups  
 (P < 0.05)  
 
 
 
 Table 4. Muscle fibre type, CSA, contractile protein and Cr (mean ± SE) 
*Greater increase than PRO-CHO; †Greater increase than PRO; # training effect all groups (P < 
0.05)  
 PRO PRO-CHO Cr-PRO-CHO 
P  
Group x 
Time 
%Type -1 
PRE 
POST 
 
40.9 ± 1.9 
40.0 ± 0.9 
 
37.9 ± 2.9 
35.7 ± 3.0 
 
40.3 ± 1.6 
38.5 ± 2.0 
0.345 
%Type-IIa 
PRE 
POST 
 
44.0 ± 1.4 
45.1 ± 1.6 
 
45.6 ± 2.1 
48.6 ± 2.2 
 
47.4 ± 2.2 
51.4 ± 3.5 
0.598 
%Type-IIx 
PRE 
POST 
 
15.1 ± 1.0 
15.0 ± 1.0 
 
16.5 ± 1.0 
15.7 ± 1.0 
 
13.8 ± 1.0 
14.1 ± 1.0 
0.410 
Type 1 CSA (µm2) 
PRE 
POST#
 
2895 ± 193 
3244 ± 213 
 
3079 ± 516 
3480 ± 497 
 
3129 ± 271 
3659 ± 208 
0.396 
Type IIa CSA (µm2) 
PRE 
POST#
 
4519 ± 242 
5136 ± 231 
 
4662 ± 501 
5416 ± 518 
 
4529 ± 383 
5886 ± 315*†
0.002 
Type IIx CSA (µm2) 
PRE 
POST#
 
3798 ± 277 
4402 ± 261 
 
4370 ± 531 
5007 ± 486 
 
3905 ± 403 
4864 ± 316*†
0.024 
Contractile protein (mg-1g) 
PRE 
POST#
 
57.8 ± 2.9 
78.4 ± 3.1 
 
55.8 ± 2.0 
76.3 ± 1.0 
 
57.1 ± 1.3 
89.1 ± 1.5*†
0.001 
Total Cr (mmol-1kg dry wt)  
PRE 
POST 
 
117.5 ± 2.1 
111.2 ± 6.8 
 
119.5 ± 4.7 
109.6 ± 7.1 
 
115.8 ± 4.4 
119.8 ± 4.2 
 
0.289 
